Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Pharmaceuticals filed suit against VGXI, a subsidiary of South Korea’s GeneOne Life Sciences, last month, accusing it of not transferring technical details pertaining to manufacturing doses of INO-4800, Inovio’s DNA vaccine compound with promising results against SARS-CoV-2. Inovio details in the lawsuit that VGXI does not possess the capacity to scale up manufacturing, which is essential … Read more

This Startup Is Innovating In Protein Sythesizers

This Startup Is Innovating In Protein Sythesizers

Protein synthesizers speed up the production of enzymes, therapeutics and lab reagents. Toronto-based Liberumbio’s product use proprietary molecular and hardware technology, enabling biological manufacturer to bring speed, scalability and to reduce cost to protein synthesis. The market size of recombinant proteins today is $119 billion. But it’s expected to reach $400 billion just by 2025. … Read more

Meet IndieBio’s San Francisco Class 10 And New York Class 1

Meet IndieBio’s San Francisco Class 10 And New York Class 1

IndieBio announced its new batches of startups in June. The life sciences startup incubator allocates each team $250,000 in seed funding plus lab and co-working space and dedicated mentorship. Afterwards, each company becomes part of a network of IndieBio alumni, investors, and biotech entrepreneurs. This is New York’s first batch, and San Francisco’s tenth. Though … Read more

Synthetic Biology Features Prominently In Pershing Square Foundation’s Recent Funding Awards To Fight SARS-CoV-2 Virus

The Pershing Square Foundation recently announced that it has awarded $3 million to nineteen recipients at ten academic research institutions in furtherance of conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combating SARS-CoV-2, The Pershing Square Foundation (the “Foundation”) worked with its … Read more

Eligo Bioscience Targets Precision Medicine

Eligo Bioscience Targets Precision Medicine

Eligo Bioscience, is a Paris-based next-generation microbiome precision medicine company Eligo Bioscience is pioneering the development of phage-derived DNA delivery vectors for microbial species involved in a number of diseases areas, including infectious diseases, inflammatory diseases and auto-immune diseases. Eligo Bioscience’s EligobioticsTM Plaform EligobioticsTM platform enables the production of DNA delivery vectors derived from phage-like … Read more

IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more